BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  Outset Medical to Present at Upcoming Investor Conferences

  Outset Medical, Inc. today announced that members of management will participate in fireside chats at two upcoming investor conferences.

  April 25, 2023

   · 

  1 min read
• Biotech Bay

  Exo Works™ Achieves HITRUST and SOC 2 Type II Certifications, Meeting Highest Bar for Patient Data Security

  Exo® announced that Exo Works™, the company’s point-of-care ultrasound workflow solution, has earned Certified status for information security by HITRUST and has successfully completed the Service Organization Control Type II certification.

  April 25, 2023

   · 

  3 min read
• Job Trends

  Abbott’s Life Support System Receives New FDA Clearances to Help Doctors Treat More Critically Ill Patients

  Abbott (NYSE: ABT) today announced two new clearances from the U.S. Food and Drug Administration (FDA) for the company’s industry-leading life support system.

  April 25, 2023

   · 

  4 min read
• Deals

  BioLineRx Regains Compliance with Nasdaq Minimum Bid Price Requirement

  BioLineRx Ltd. today announced that it has received formal notice from The Nasdaq Stock Market, LLC (“Nasdaq”) stating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550.

  April 25, 2023

   · 

  5 min read
• Business

  Alkermes Announces Second Interim Award in Janssen Pharmaceutica Arbitration

  Alkermes plc (Nasdaq: ALKS) today announced that on April 19, 2023 it received a second interim award (the “Second Interim Award”) from the arbitral tribunal (the “Tribunal”) in its arbitration proceedings in respect of two license agreements with Janssen Pharmaceutica N.V.

  April 25, 2023

   · 

  4 min read
• Lone Star Bio

  DecisionDx®-Melanoma Provides Improved Risk Stratification Over American Joint Committee on Cancer (AJCC) Staging Alone in Stage I Melanoma Patients

  DecisionDx ® -Melanoma Provides Improved Risk Stratification Over American Joint Committee on Cancer (AJCC) Staging Alone in Stage I Melanoma Patients.

  April 25, 2023

   · 

  6 min read
• Genetown

  Parthenon Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of PRTH-101, a Novel DDR1 Inhibitor for the Treatment of Immune-Excluded Solid Tumors

  Parthenon Therapeutics today announced that the first patient has been dosed with PRTH-101 in a Phase 1, first-in-human clinical trial for patients with immune-excluded solid tumors.

  April 25, 2023

   · 

  3 min read
• Business

  908 Devices to Report First Quarter Financial Results on May 9, 2023

  908 Devices Inc. today announced it will report financial results for the first quarter 2023 before market open on Tuesday, May 9, 2023.

  April 25, 2023

   · 

  1 min read
• Business

  Elucid Names Scott Huennekens Executive Chairman of the Board

  Elucid, Inc today announced that it has named Scott Huennekens executive chairman of its board of directors.

  April 25, 2023

   · 

  3 min read
• Lone Star Bio

  Orthofix Expands Solutions for Minimally Invasive Spine Procedures with the Full Commercial Launch of Two Access Retractor Systems

  Orthofix Medical Inc today announced the full commercial launch of two access retractor systems to aid surgeons during minimally invasive spine (MIS) procedures.

  April 25, 2023

   · 

  5 min read